Bilateral Vs. Unilateral Neuromobilization in Carpal Tunnel Syndrome

Launched by GAZI UNIVERSITY · Aug 12, 2024

Keywords

ClinConnect Summary

This clinical trial is looking to find out if treating Carpal Tunnel Syndrome (CTS) with neuromobilization on both hands at the same time is more effective than treating just the affected hand. Carpal Tunnel Syndrome is a condition that causes pain, numbness, and weakness in the hand due to pressure on a nerve in the wrist. The study is currently recruiting participants who are at least 18 years old and have been diagnosed with CTS but do not have other hand conditions that could interfere with the treatment.

To take part in this trial, individuals should not have had any surgeries, injuries, or recent injections in the affected hand, and they should not be involved in other treatment programs during the study. Participants can expect to receive the specified neuromobilization treatment and will be monitored throughout the trial. This study aims to improve understanding of the best treatment options for CTS, which could benefit many people suffering from this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals diagnosed with CTS,
• • Aged 18 and above,
• • Without any other conditions in either upper extremity (such as trigger finger, osteoarthritis, tenosynovitis)
• Exclusion Criteria:
• • Individuals with a history of surgery, trauma, or fracture in the same upper extremity,
• • Those who have received an injection for CTS in the last 3 months,
• • Those with poor cooperation,
• • Those participating in any other treatment program during the study,
• • Those with a history of uncontrolled systemic diseases or systemic diseases involved in the etiology of CTS (such as diabetes, thyroid diseases, rheumatoid arthritis),
• • Those who have used orthoses regularly and/or received physiotherapy in the last 3 months,
• • Individuals with marked thenar atrophy requiring early surgical intervention